Interestingly, tumors carrying BRCA2 mutations had a significantly higher tumor mutation burden than wild type OSs (mean of 172.25 ± 54.45 SE vs. 55.27 ± 6.37, p = 0.016; Mann–Whitney U test). This evidence concerns the gene BRCA2 and neoplasm.